Introduction
============

Microcalcifications are seen in benign and malignant lesions. Stereotactic biopsy along with digital equipment has made targeting these more accurate. This is a retrospective audit of 147 core biopsies done at the Colchester--Chelmsford screening unit.

Method
======

All patients who had core biopsies for assessment of microcalcifications are included in this study and were discussed in the multidisciplinary team meeting.

Results
=======

Seventy patients had benign microcalcifications seen both on X-ray and pathology. Fifty-two patients had malignant calcifications associated with ductal carcinoma *in situ*(DCIS).

Of the remaining 25 patients, five had a repeat core, which showed benign calcification, and three were discussed at the multidisciplinary team meeting (calcification seen on X-ray and not on pathology) and discharged to recall in 1 year\'s time. Table [1](#T1){ref-type="table"} shows the results of the other 17 patients.

  Microcalcification seen                                                Final diagnosis postsurgery       
  ---------------------------------------------------------------------- ----------------------------- --- ----------------------
  Seen in 10 patients                                                    None                          7   3
  Six patients not seen                                                                                2   4 (2 had B4 on core)
  One patient microcalcification seen benign but R5 microcalcification                                     DCIS

Discussion
==========

This audit shows that 11.9% of patients had a diagnostic operation, as the core biopsy could not give a definitive diagnosis. The question whether this can be improved by repeat core or mammotome cores remains to be answered.
